Multiple Myeloma

>

Latest News

Multiple Myeloma Experts Face Off on Sequencing Therapy Options
Multiple Myeloma Experts Face Off on Sequencing Therapy Options

November 21st 2024

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Optimal Sequencing Between CAR T and Bispecifics in Multiple Myeloma
Optimal Sequencing Between CAR T and Bispecifics in Multiple Myeloma

November 20th 2024

Using Real-World Data to Form GPRC5D Therapy Strategies in R/R Multiple Myeloma
Using Real-World Data to Form GPRC5D Therapy Strategies in R/R Multiple Myeloma

November 18th 2024

Survival data from the interim analysis of the phase 3 DREAMM-7 trial will be presented at the 2024 ASH Annual Meeting.
Belantamab Mafodotin Combo Significantly Improves OS in Multiple Myeloma

November 14th 2024

Early results from the iMMagine-1 trial show anito-cel as a promising therapy in relapsed/refractory multiple myeloma.
Anito-Cel Shows Promising Results in Relapsed/Refractory Multiple Myeloma

November 10th 2024

Latest CME Events & Activities